Le Lézard
Classified in: Ebola virus, Health, Covid-19 virus
Subject: MRR

Global In Vitro Diagnostic (IVD) Procedure Volumes Report 2023-2028: Total Number of IVD Tests by Region and Selected Countries/Average and Total Worldwide Cost of Various IVD Tests


DUBLIN, Jan. 4, 2024 /PRNewswire/ -- The "In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers.

The market analysis in the report saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.

Scope

Data statistics appearing in this report correlate to IVD procedures based on commercially sold and distributed tests. Procedures that employ laboratory-developed tests (LDTs) and tests implemented for research purposes only are excluded from the analysis.

Global volumes of various IVD procedures are presented in millions and reflect the evaluation of a single analyte, marker, or other variable of interest. It should be noted that some IVD tests involve more than one procedure as they provide for the analysis of multiple analytes.

Global sales of IVD products are expressed in current United States dollars and reflect sales for the year 2023 and forecasts for the 2028 period. A table that measures the total amount of IVD product sales against the total volume of IVD procedures is presented for each major testing category.

The IVD procedures report presents projections covering the 2023 to 2028 period for:

Key Topics Covered:

Chapter One: Executive Summary

Chapter Two: Introduction

Chapter Three: IVD Testing Segments

Chapter Four: Global IVD Markets

Chapter Five: Point-of-Care (POC) Procedures

Chapter Six: Clinical Chemistry Procedures

Chapter Seven: Immunoassay Procedures

Chapter Eight: Molecular Testing Procedures

Chapter Nine: Laboratory-Based Hematology Procedures

Chapter Ten: Coagulation Testing Procedures

Chapter Eleven: Microbiology Procedures

Chapter Twelve: Blood Grouping/Typing Procedures

Chapter Thirteen: Histology/Cytology Procedures

Chapter Fourteen: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/1hxwyb

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

at 03:00
Clarivate Plc , a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligencetm solution, featuring a new post-approval variations module. The module for post-approval variations...

at 03:00
Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting,...

at 02:58
Today, 2 May 2024, is the last day of trading in unit rights in SciBase Holding AB (publ) ("SciBase" or the "Company") rights issue of units of up to approximately SEK 15 million (the "Rights Issue"). The Rights Issue was resolved by the Board of...

at 02:34
SciBase Holding AB ("SciBase") (STO: SCIB), a pioneer in skin cancer detection and prevention, and prediction in dermatology, further deepens their commitment to patients and dermatologists during US Skin Cancer Awareness Month by highlighting the...

at 02:14
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Dra. Beatriz Guil of Universitario de Canarias in the Canary Islands and Dr. Carlos Milliani of Universitario de Fuenlabrada in...

at 02:00
YourBio Health, a Boston-based pioneer in remote, capillary whole blood collection technology, congratulates Myriad Genetics for having sold one million of its leading SneakPeek® Tests. Since 2021, YourBio Health is pleased to have contributed over...



News published on and distributed by: